{"id":"W2982785161","doi":"10.1136/annrheumdis-2019-216118","title":"Efficacy and safety of ixekizumab through 52 weeks in two phase 3, randomised, controlled clinical trials in patients with active radiographic axial spondyloarthritis (COAST-V and COAST-W)","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":126,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Alberta","funders":"Eli Lilly and Company","keywords":"Ixekizumab; Medicine; Placebo; Internal medicine; Disease; Secukinumab; Pathology; Psoriatic arthritis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005004566,0.001789209,0.004464718,0.0005613024,0.000683209,0.001509623,0.001358482,0.002792019,0.004657451],"category_scores_gemma":[0.003999763,0.001161034,0.00408774,0.0005859771,0.001920924,0.002269861,0.0006882055,0.004594337,0.0009403188],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001064575,"about_ca_system_score_gemma":0.001649533,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001853977,"about_ca_topic_score_gemma":0.003451855,"domain_scores_codex":[0.9977542,0.001175559,0.0002068069,0.0004307782,0.0001171085,0.0003154923],"domain_scores_gemma":[0.9975201,0.0007149457,0.0006185116,0.0002315529,0.0001709804,0.000743882],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9812928,0.003419576,0.000631773,0.0004229776,0.0007731699,0.00002199264,0.0001060104,0.0002463908,0.001923057,0.00005726319,0.0003920457,0.01071308],"study_design_scores_gemma":[0.9390376,0.05778719,0.002049707,0.00003092812,0.0003342835,0.0000210351,0.00002655511,0.0001511729,0.0002433597,0.00005706178,0.0002431917,0.00001798144],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9858536,0.007965968,0.0006821292,0.0005944329,0.0003987105,0.002102929,0.0009943371,0.00009756901,0.001310431],"genre_scores_gemma":[0.9869794,0.003123332,0.002126536,0.0009045398,0.0003365409,0.003045432,0.001294689,0.00004250211,0.002147117],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005004566,"threshold_uncertainty_score":0.02646703,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04129208380556876,"score_gpt":0.3747485104885506,"score_spread":0.3334564266829818,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}